Haematologica (Apr 2020)
Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with <i>GATA1</i> mutation
- Yoko Nishinaka-Arai,
- Akira Niwa,
- Shiori Matsuo,
- Yasuhiro Kazuki,
- Yuwna Yakura,
- Takehiko Hiroma,
- Tsutomu Toki,
- Tetsushi Sakuma,
- Takashi Yamamoto,
- Etsuro Ito,
- Mitsuo Oshimura,
- Tatsutoshi Nakahata,
- Megumu K. Saito
Affiliations
- Yoko Nishinaka-Arai
- Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;
- Akira Niwa
- Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;
- Shiori Matsuo
- Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;
- Yasuhiro Kazuki
- Chromosome Engineering Research Center, Tottori University, Tottori, Japan;
- Yuwna Yakura
- Chromosome Engineering Research Center, Tottori University, Tottori, Japan;
- Takehiko Hiroma
- Perinatal Medical Center, Nagano Children's Hospital, Nagano, Japan;
- Tsutomu Toki
- Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan;
- Tetsushi Sakuma
- Division of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan;
- Takashi Yamamoto
- Division of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan;
- Etsuro Ito
- Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan;
- Mitsuo Oshimura
- Chromosome Engineering Research Center, Tottori University, Tottori, Japan;
- Tatsutoshi Nakahata
- Center for iPS cell Research and Application, Kyoto University, Kyoto, Japan
- Megumu K. Saito
- Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;
- DOI
- https://doi.org/10.3324/haematol.2019.242693
- Journal volume & issue
-
Vol. 106,
no. 2
Abstract
No abstracts available.